Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Uwe Muenster

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Journal of Pharmaceutical Sciences|November 4, 2018
Application of a Refined Developability Classification SystemJulian Rosenberger, James Butler, Uwe Muenster, et al.
Journal of Pharmaceutical Sciences|August 22, 2016
The Impact of Handling and Storage of Human Fecal Material on Bacterial ActivityEleni Karatza, Maria Vertzoni, Uwe Muenster, et al.
Pharmaceutical Research|June 5, 2008
Characterization of substrates and inhibitors for the in vitro assessment of Bcrp mediated drug-drug interactionsUwe Muenster, Birgit Grieshop, Karsten Ickenroth, et al.
International Journal of Pharmaceutics|October 15, 2017
Ex vivo evaluation of degradation rates of metronidazole and olsalazine in distal ileum and in cecum: The impact of prandial stateEleni Karatza, Constantinos Goumas, Uwe Muenster, et al.
Vitamins and Hormones|March 1, 2011
Antagonism of activin by activin chimerasUwe Muenster, Radhika Korupolu, Ratindra Rastogi, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 26, 2011
In vitro and in vivo P-glycoprotein transport characteristics of rivaroxabanMark Jean Gnoth, Ulf Buetehorn, Uwe Muenster, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|October 2, 2018
Evaluating the clinical importance of bacterial degradation of therapeutic agents in the lower intestine of adults using adult fecal materialMaria Vertzoni, Elisabeth Kersten, Dorina van der Mey, et al.
The Journal of Biological Chemistry|September 1, 2005
An activin-A/C chimera exhibits activin and myostatin antagonistic propertiesUwe Muenster, Craig A Harrison, Cynthia Donaldson, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|December 19, 2016
Nanocrystals embedded in chitosan-based respirable swellable microparticles as dry powder for sustained pulmonary drug deliveryRui Ni, Jing Zhao, Qiaoyu Liu, et al.
The Journal of Biological Chemistry|December 7, 2007
Activin A/bone morphogenetic protein (BMP) chimeras exhibit BMP-like activity and antagonize activin and myostatinRadhika V Korupolu, Uwe Muenster, Jessica D Read, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Journal of Pharmaceutical Sciences|November 4, 2018
Application of a Refined Developability Classification SystemJulian Rosenberger, James Butler, Uwe Muenster, et al.
Journal of Pharmaceutical Sciences|August 22, 2016
The Impact of Handling and Storage of Human Fecal Material on Bacterial ActivityEleni Karatza, Maria Vertzoni, Uwe Muenster, et al.
Pharmaceutical Research|June 5, 2008
Characterization of substrates and inhibitors for the in vitro assessment of Bcrp mediated drug-drug interactionsUwe Muenster, Birgit Grieshop, Karsten Ickenroth, et al.
International Journal of Pharmaceutics|October 15, 2017
Ex vivo evaluation of degradation rates of metronidazole and olsalazine in distal ileum and in cecum: The impact of prandial stateEleni Karatza, Constantinos Goumas, Uwe Muenster, et al.
Vitamins and Hormones|March 1, 2011
Antagonism of activin by activin chimerasUwe Muenster, Radhika Korupolu, Ratindra Rastogi, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 26, 2011
In vitro and in vivo P-glycoprotein transport characteristics of rivaroxabanMark Jean Gnoth, Ulf Buetehorn, Uwe Muenster, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|October 2, 2018
Evaluating the clinical importance of bacterial degradation of therapeutic agents in the lower intestine of adults using adult fecal materialMaria Vertzoni, Elisabeth Kersten, Dorina van der Mey, et al.
The Journal of Biological Chemistry|September 1, 2005
An activin-A/C chimera exhibits activin and myostatin antagonistic propertiesUwe Muenster, Craig A Harrison, Cynthia Donaldson, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|December 19, 2016
Nanocrystals embedded in chitosan-based respirable swellable microparticles as dry powder for sustained pulmonary drug deliveryRui Ni, Jing Zhao, Qiaoyu Liu, et al.
The Journal of Biological Chemistry|December 7, 2007
Activin A/bone morphogenetic protein (BMP) chimeras exhibit BMP-like activity and antagonize activin and myostatinRadhika V Korupolu, Uwe Muenster, Jessica D Read, et al.
Pageof 3